US Administration Scrutiny on Chinese Pharma R&D Raises Market Concerns

ソース：

[1] China’s Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington (https://www.thedailyupside.com/industries/hea ...)[2] "A single regulatory decree cannot hinder industry trends; many institutions remain optimistic about the development of innovative pharmaceuticals." - Moomoo (https://vertexaisearch.cloud.google.com/groun ...)[3] 48 billion dollars in half a year! How is China reshaping the global pharmaceutical landscape behind record-breaking trade deals? (https://vertexaisearch.cloud.google.com/groun ...)